chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 centimeter roundish area at the injection site; Slight itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Slight itching at the injection site) and VACCINATION SITE ERYTHEMA (4 centimeter roundish area at the injection site) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MOMETASONE FUROATE (ASMANEX), AZELASTINE, FEXOFENADINE, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), LEVOTHYROXINE, FLUOXETINE HYDROCHLORIDE (PROZAC), BISOPROLOL, BUPROPION and ETHINYLESTRADIOL, NORETHISTERONE (OVCON-35) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Slight itching at the injection site). On 07-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (4 centimeter roundish area at the injection site). At the time of the report, VACCINATION SITE PRURITUS (Slight itching at the injection site) and VACCINATION SITE ERYTHEMA (4 centimeter roundish area at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments.  Treatment medications were not provided.
Received vaccines, MMR & Varivax on 1/24/2000, per history. Fever with diarrhea, vomiting 1/24/2000, sore (herpes labialis or chicken pox) on lower lip mucosa.
Patient had been prescreened by volunteer. Patient had answered not to have received any vaccines in the last 4 weeks. Nurse (I) asked patient if she was ok and reason for her oxygen tank. Pt says she is ok but has COPD and not tired. I ask if she is here for the flu & Tdap vaccines as to what pt said: "Yes". Pt realized she had received flu 9/17/12. Pt was observed for 20 minutes and she was AAO x 4 and a nurse business card was provided.
@1543 CW notified RN patient was c/o dizziness and headache while in monitoring area. Patient was vaccinated at 1540.  @1545 RN placed patient in private room, attempted to lay in chair but patient refused. Water was provided to patient.  @1546 Vital signs taken; BP: 165/103, P: 70, SPO2: 98%. MD was notified of patient.  @1548 MD arrived to assess patient. Patient denied any more dizziness or headache and stated, ?I feel fine?. MD requested to lay patient and repeat vital signs. BP: 171/94, P: 96, SPO2: 99%, MD requested larger BP cuff for vital signs.  @1550 MD took BP manually with a larger BP cuff, BP: 115/70. Per MD, patient is ok to go home.  @1552 Patient was sat back up slowly in chair. Denied any dizziness or headache. Gave patient a few minutes in the sitting position before standing. Family member was at patient?s side. @1558 Patient stood up and stated, ?I feel fine, I?m ok to go?. Patient ambulated a steady gait and left the clinic in stable condition accompanied by family member.
Information has been received from a certified medical assistant concerning a 13 year old female who on 5/7/02 and on 6/19/03 was vaccinated with a first (lot # 642671/0103M) and a second dose (lot # 645482/0153N) of hepatitis A virus vaccine inactivated (0.5ml), respectively. There was no concomitant medication. The patient had some stomach pain and nausea after the first dose, which reportedly subsided. Following the second dose, the patient had a local reaction with a goose egg size bump, nausea, vomiting, abdominal pain, diarrhea and a generalized rash. The patient was taken to the emergency room and required treatment was noted. She was not admitted. Additional information has been requested.
Given at approximately 8:45 am; 11:30 AM employee experiencing generalized itching and face flushed. Refused Epi. Refused EM5CK. Denied difficulty breathing, chest tightness or chest pain. No swelling of throat, no wheezing or shortness of breath. Had family member bring her an anti-histamine (Zyrtec); took 2 tablets at 1:30 pm. 11/16/15 denied further effects.
Patient had Bell's Palsy. Patient was prescribed VALTREX 500mg (1 tab twice a day) and Triamcinolone 0.1% cream (Apply twice a day).
Patient's caregiver reported to pharmacy staff today that the patient was hospitalized ~1 week after receiving her COVID vaccination for blood clots and has since been in the hospital. She stated she thought the patient's hospital physician said the patient may had some type of clotting disorder which may have contributed, but recommended she let us know to report since she got the vaccine with us. The patient is currently still in the hospital per the caregiver and has also had a heart attack since being inpatient.
Patient was given a moderna booster 0.25ml IM exactly 20 days prior to turning 18 no actual adverse events experienced thus far.
I received the Moderna Bivalent booster on 9/11/2022. On 10/31/2022, I woke up and felt kind of like I had a cold. I had a cough, nasal drainage, sinus congestion, lightheadedness, fatigue. I also felt like my temperature wasn't quite right, but I didn't have a fever. I took an antigen test, which yielded a negative result. I felt even worse on 11/1/2022. The aforementioned symptoms were magnified, only they were now also accompanied by a cough that was trying to be productive, though I couldn't cough much up. I took another antigen test, which yielded a positive result. I have been taking an antigen test every day ever since, and today marks the first day that I have had a negative result. Since having COVID-19, I have found that my breathing has become more rapid. I have treated my symptoms with OTC medicines like guaifenesin, ADVIL, and occasionally SUDAFED. I have also been using an albuterol inhaler as needed. When the symptoms first hit, I used it daily up until 11/5/2022; ever since then, I have used it every other day. I am also being treated by a naturopathic doctor. He has recommended that I drink half my weight in water every day (to flush out the virus), and 600 mg of NAC (4 capsules a day), 50 mg of zinc a day with a meal. He has also suggested that I take quercetin and probiotics, which I am receiving through foods like apples, blueberries, and yogurt. I was also told to sleep as much as possible. At the time of this writing, I am better, though I am not quite yet at normal baseline.
Reported right upper arm swollen, warm to touch, and tender on 08-10-2018. Child came home from school with arm swollen. No doctor appointment made per grandmother or urgent care visit needed. Vaccines where given on 08/07/2018.
14APR97 pt exp a febrile sz;pt was seen @ ER for 3 or 4hr;URI sx present @ time of vax;pt afeb 97.4;13APR97 T103-104;pt seen in clinic w/symptomatic tx;that evening was found shaking w/eyes rolled back into head;rt upper lobe infiltrate;
Patient discovered rash on same arm as injection this morning six days after vaccination. Patient states the area started hurting Tuesday night and rash appeared Wednesday morning. Patient also reports experiencing some pain near the injection site.
Swelling in Eye: Mild.  Reaction happened after first vaccine No other sx noted. Pt did not complain of any other issues  Got vaccinated at approx 3:30 and waited until 4:00pm Pt was given 25mg PO of Benadryl approx 5 mins after vaccine.  Eye had slight swelling after waiting 30 minutes,  had benadryl 20 minutes before. Felt okay w/ no other reactions. Was okay to leave
My arm started hurting.  Then the top part of my stomach started hurting.  I also had nausea and not feeling like I wanted to eat.  This has gone on since October 28th.  I went to my PCP about this.  There was no test or diagnosis with this visit.  They did refer me to Health Center.
He reports that within hours of receiving his 6th anthrax vaccine on April 2, 2000, his arm started to become red, and slightly swollen. The following day he noticed that the reddened area was 3X2 inches. On the second day following the vaccination the reddened area measured 5X3 inches. He spent the day in class and at 1800 his arm was swollen from the elbow to the shoulder. There was also a slightly raised rash and the skin of his arm became tight. He reported to the emergency room where a border was drawn around the swelling. Within 30 minutes the redness and swelling extended outside of the border. He was hypertensive at the time of the ER visit (164/107). He also reports that his hand was numb and pulses were difficult to palpate. It was difficult to bend his arm. Benadryl 25MG every 4-6 hours as needed and Dicloxacillin 500MG four times daily for one week were prescribed. He was instructed to keep the arm elevated and use warm soaks. He reports that the symptoms "diminished noticeably" with in 2 days and gradually resolved over a period of a couple of days. The numbness in his hand lasted for one day.
Pt recvd 3 doses of Engerix-B vax 22FEB, 25MAR, & 26AUG91 & it was determined that pt did not respond to vax; booster was given 13JAN92;
Was diagnosed with A-fib. Healthcare professional provided patient with blood thinners. Patient was hospitalized for 5 days. Was unable to walk.  Has seen 3 cardiologists.
Information has been received from a nurse concerning a 19 year old female with no drug allergies and no medical history, who on 08-MAY-2007 was vaccinated intramuscularly in the right deltoid with a second dose of Gardasil. Concomitant therapy included LOESTRIN. Almost immediately after receiving the vaccination the patient fainted in the office in the waiting room. The patient was kept lying down with ice on her head and was observed for 30 minutes. It was reported that the patient was not hospitalized and the patient had recovered before leaving the office on her own. No laboratory diagnostics were performed and there were no illness at the time of vaccination. No product quality complaint was involved. Additional information has been requested. This is in follow-up to report (s) previuosly submitted on 7/16/2007. Additional information has been requested.
While exercising on the morning of 4/11, received a sudden, severe headache on the left side of my head. It started in my neck, moved up through my skull, and ended above my left eye. The feeling gradually improved with time, stretching, and acetaminophen. For more than 24 hours, a mild feeling persisted. On 4/13, the left side of my neck is still stiff and my left eye has a light throbbing.
At approximately 10 PM 12/06/2001 had chills lasting about 3 hours then starting vomiting and vomited about every hour from 1 AM to 6 AM. Then got headache which lasted until noon when she took aspirin. She felt welt weak and washed out until Saturday evening.
Patient described swelling of hands, feet, and face. Also skin color was red. She took an antihistamine pill. The RPh on duty told her to go to the urgent care.
Chills, fatigue, soreness, headache; Chills, fatigue, soreness, headache; Chills, fatigue, soreness, headache; Chills, fatigue, soreness, headache; This is a spontaneous report from a contactable consumer (patient). A 26-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6199, Expiration date: Unknown), via an unspecified route of administration, in Left arm on 09Mar2021 at 03:45 (at the age of 26-years-old) as 2ND DOSE, SINGLE for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took first dose of historical vaccine bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL1283, Expiration date: Unknown), via an unspecified route of administration, in Left arm on 16Feb2021 (at the age of 26-years-old) as 1ST DOSE, SINGLE for Covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19, prior vaccination. The patient has been tested for COVID-19, post vaccination. On 10Mar2021, the patient had experienced chills, fatigue, soreness, headache. No treatment received for the adverse events. The patient underwent lab tests and procedures which included Nasal Swab (sars-cov-2 test): unknown on an unspecified date. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a patient who 4 years ago was vaccinated with 3 shots of Hepatitis B virus vaccine.  Subsequently, the patient now has experienced developmental delays.  No further information was available.  Additional information has been requested.
patient was fine during vaccine administration and for a few minutes afterwards. When the family was walking away from the pharmacy the patient fell down and said that she felt really dizzy. Her mom brought her over to a chair, and she was given a water bottle. Parents were spoken to about syncope type reactions and were asked if they wanted us to call an ambulance or just monitor for a while in the store, parents refused any additional help. After a short time, the family left together appearing well.
I received Pertussis vaccine on Thursday 8-17-06, on Tuesday 8-22-06, I suddenly developed pain in shoulders, elbows, hips and knees bilaterally.  The pain was severe and I had a low grade temperature of 99.9 F.  The pain continued through Thursday 8-24-06 and I missed work on 8-23-06.  I could hardly walk due to the pain.
Shivering; This case was reported by a consumer via interactive digital media and described the occurrence of shivering in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shivering. On an unknown date, the outcome of the shivering was unknown.   It was unknown if the reporter considered the shivering to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 10-JUL-2022 Reporter's comment: This case was reported by a patient via interactive digital media.The reporter asked usually when did you feel the side effects such as shivering from the time you get vaccinated. Follow-up would not possible as no contact details were available.
pain; swelling; elevated KRP; elevated ESR; This non-serious case was reported by a consumer via sales rep and described the occurrence of pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: pain), swelling (Verbatim: swelling), c-reactive protein increased (Verbatim: elevated KRP) and erythrocyte sedimentation rate increased (Verbatim: elevated ESR). The outcome of the pain, swelling, c-reactive protein increased and erythrocyte sedimentation rate increased were not reported.   It was unknown if the reporter considered the pain, swelling, c-reactive protein increased and erythrocyte sedimentation rate increased to be related to Shingrix.     It was unknown if the company considered the pain, swelling, c-reactive protein increased and erythrocyte sedimentation rate increased to be related to Shingrix.   Additional Information: GSK receipt date: 20-Jun-2023 The patient received Shingrix, 2nd dose 1 year prior to the reporting and reported pain, swelling and elevated C-reactive protein (CRP) and Erythrocyte sedimentation rate (ESR) The reporter did not agree to follow up from GlaxoSmithKline.
Probable mild case of varicella after exposore. Received Varivax vaccine 03/04/1998.
Fever of 102F lasting ~4h, fully resolving after ~12h.  Moderate muscle and joint pain, mild headache treated with acetaminophen, resolving after 24h.
Extreme pain, swelling, couldn't lift arm, after 10 days site below shot, skin became pebbled, then skin started falling off like a skin eating disease. After now 11 days still cannot use arm and have had to go to a doctor for help.
1 1/2 days after vaccine given, child developed a pustule rash (L) leg > (R) leg; Couple pustules to face, (R) arm & (L) wrist. No fever reported. Current temp 98.6.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (BNT162B2), on 15Mar2022 at 13:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 56 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Positive; (May2022) Negative. Therapeutic measures were taken as a result of covid-19, drug ineffective.  Clinical course: After dramatically reducing both symptoms and viral load (as measured by intensity of positive test on health rapid antigen test), symptoms began to return on 28May2022 and are nearly as severe as Day 1 of treatment. Intensity of positive antigen test, after testing negative on Day 5 of Paxlovid treatment, was now stronger than any earlier test. The patient had no other medications in 2 weeks. The patient was treated with Paxlovid (lot number: FY7031) for covid-19. Treatment start date was 22My2022 and stop date was 26May2022. The patient had no known allergies. The patient had OTC medications as treatment for the adverse event.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information in the case report, a causal association between reported events and suspect BNT162B2 cannot be excluded.
Patient had numbness and tingling in left hand and fingers. Held patient for an additional 15 minutes and symptoms got worse. Staff took vitals BP: 152/107 and pulse: 75. Patient taken to ER for examination via wheelchair.  At ER, pt stated that after receiving her first dose of the COVID vaccine, she the fingers of her left hand became tingly and then blood pressure became elevated while at the clinic. Patient stated she does have a history of anxiety and that taking shots does make her nervous and upset.  She does have Xanax at home that she can take but she has not taken any today. She also does have a history of high blood pressure and does have high blood pressure medicine which she did take today. Pt discharged home, with instructions to follow up with primary care provider, return to clinic in 4 days if no better, or return sooner to clinic/ER if worsening symptoms.  1/29/21: Pt received the 2nd dose of vaccine with no issue.
Chills; Fever (highest reading 102.6); Headache; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 30Apr2021 at 13:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history includes asthma, eczema, thyroid cancer survivor, breast cancer survivor and allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), anastrozole (MANUFACTURER UNKNOWN) and meloxicam (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in left arm on 02Apr2021 at 13:00 as a single dose for COVID-19 immunisation. On 01May2021 at 02:45, the patient experienced that chills, fever (highest reading 102.6), headache, started 12 hours after second dose of vaccine and lasted 30 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with extra strength paracetamol (Tylenol) for every 6 hours. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever and headache were resolved on 02May2021 at 08:45, after the duration of 30 hours.  No follow-up attempts are needed. No further information is expected.
Myalgia Soreness and pain to RT Arm, pt is going to Urgent Care this morning for assessment. Narrative:
Patient reports that the day following the vaccination she received a red band like rash on the upper arm - red and heat has been subsiding and was barely visible today 10/30 (3 days after she noticed the red mark).
1. Elevated levels of tinnitus to the point that it?s noticeable/irritating/life impacting all day and every day. Previously tinnitus was only noticeable during quiet periods of time. - no treatment known  2. Jaw tightness and TMJ spasms  - massage or muscle relaxer, no real effective treatment found yet 3. Very bad Headaches (migraine level), tightness in a band around sides and back of head. -Naratiptan/sumatriptan with varying levels of success for treatment, nothing satisfactory
Discharge Date: 09/07/2023 Discharge Provider: MD Primary Care Provider : MD   Admission Date: 8/29/2023 Admitting Diagnoses: COVID-19   Discharge Date: 9/7/2023  Details of Hospital Stay PRESENTING PROBLEM: COVID-19   HOSPITAL COURSE: Patient is a 92-year-old male with history of hypertension who presented from independent living with cough, fever and shortness of breath.  Vitals were stable in the emergency department.  Chest x-ray was unremarkable.  COVID-19 PCR was positive. He was admitted to the hospitalist team for further management.    Despite initial aggressive treatment, the patient was noted to become more lethargic and had difficulty managing his secretions. Given his decline, palliative care was consulted. Medications were started which have been successfully controlling his secretions.    Family members elected for comfort-focused care for patient. Patient was discharged back to Independent Living on 9/7 with hospice.
Daughter was getting ready for school noticed hair shedding and had headaches throughout the day. This has continued to happen along with dehydration since then. She has completely lost all her hair and currently wearing a wig to school.
mom states pt recvd vax around 4PM pt started crying for over 3 hrs, went to sleep woke up & started crying again; mom also noted some twitching movements MD called; pt taken to MD ;
Post vax, the pt's lower lip swelled, she developed itching all over, joint pain, and fever.
50 hours post vax, the pt developed irritability. Admitted the next day for fever of 104-105 and irritability. No source for fever. Had mild red rash at onset.
Nurse administered IPV intradermally-inner aspect of (L) forearm, instead of PPD for tuberculosis screening.
From the 9th day after the shot, bumps began to form on the underside of both forearms. These developed into a rash that covered both forearms, scalp, back and belly which continued through day 14. My doctor said to take antihistamines which also reduced the overall all feeling of illness I was experiencing. I also had sever diarrhea on about day 10 and 11.